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resumo 
 
 
 O sulforafano (SFN) é um composto que pertence à família dos isotiocianatos, 
sendo o mais estudado deste grupo, principalmente pelas suas potenciais 
propriedades anti-tumorais. Existe em grande quantidade nas crucíferas, 
sobretudo nos brócolos. Vários estudos têm demonstrado a capacidade do 
SFN em causar paragem do ciclo celular, indução da apoptose, aumento de 
espécies reactivas de oxigénio (ROS), no entanto, os seus efeitos no 
osteosarcoma, estão ainda pouco compreendidos, principalmente ao nível do 
stress oxidativo. 
O objectivo deste estudo foi investigar a capacidade do SFN induzir, in vitro, 
stress oxidativo numa linha celular de osteossarcoma humano, a MG-63, e 
compreender as vias de stress oxidativo envolvidas neste processo. 
Para tal, as células MG-63 foram expostas a diferentes concentrações de SFN 
(0, 5, 10 e 20μM) em diferentes períodos (24 e 48h). O crescimento e a 
morfologia celular foram observados através do microscópio invertido e a 
viabilidade celular determinada usando o ensaio de Trypan Blue. A avaliação 
do stress oxidativo foi realizada através da análise da actividade das enzimas 
envolvidas na destoxificação de espécies reativas de oxigénio (ROS), 
nomeadamente glutationa peroxidase, glutationa reductase e superóxido 
dismutase. A actividade antioxidante total, a glutationa reduzida e a 
peroxidação lipídica foram também analisadas, bem como a expressão de 
genes relacionados com o stress oxidativo (SOD1, SOD2, GSR, GPX1, 
GSTM1 e GSTM4 e CAT). Os ensaios enzimáticos, bem como a actividade 
antioxidante total, foram avaliadas por diferentes ensaios colorimétricos no 
leitor de microplacas, já a glutationa reduzida e a peroxidação lipídica foram 
avaliadas por fluorimetria.  
Observou-se para ambos os períodos de exposição que a maior concentração 
de SFN reduziu a viabilidade celular, relativamente ao controlo, bem como a 
actividade de todas as enzimas analisadas. A actividade antioxidante total 
aumenta com o tempo e diminui com a concentração de SFN. A actividade das 
enzimas decresce com o aumento da concentração de SFN (e com o tempo 
para concentrações de SFN elevadas). Verificou-se também um aumento da 
glutationa reduzida para concentrações de SFN baixas, embora tenha 
decrescido para valores de SFN mais elevadas.  
A expressão dos genes é concordante em geral com a actividade das 
respectivas enzimas, ou seja diminui com o aumento da concentração. No 
entanto é observada uma excepção para a SOD em que a actividade diminui 
com a concentração enquanto a expressão aumenta. Pode-se observar que a 
peroxidação lipídica diminui com a concentração.    
Como conclusão, estes resultados indicam que o SFN induz stress oxidativo 
em células de osteossarcoma humano. Propõe-se um modelo de acção para o 
stress oxidativo induzido por SFN em osteossarcoma.  
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abstract 
 
Sulforaphane (SFN) is a compound that belongs to the isothiocyanates family 
and is the most studied compound of this group, mostly due to its putative anti-
tumoral properties. It is found in large quantities in cruciferous vegetables, 
mainly broccoli.  
Several studies have shown the ability of SFN to cause cell cycle arrest, 
apoptosis induction, reactive oxygen species (ROS) formation however, its 
effects in osteosarcoma, is still poorly understood, mostly at the stress 
oxidative level. 
The aim of this study was to investigate the ability of SFN in inducing, in vitro, 
oxidative stress in the human osteosarcoma cell line MG-63. It was also an aim 
to understand the pathways of oxidative stress involved in this process.  
For these propose, MG-63 cells were exposed to different concentrations of 
SFN (0, 5, 10 and 20μM) at different times (24 and 48h). The growth and cell 
morphology were observed through an inverted microscope, and cell viability 
determined using Trypan Blue assay. The oxidative stress evaluation was 
performed by the activity analysis of antioxidant enzymes, namely, glutathione 
peroxidase, superoxide dismutase and glutathione reductase. The total 
antioxidant activity (TAA), reduced glutathione and lipid peroxidation were also 
analysed, as well as the expression of genes related to oxidative stress (SOD1, 
SOD2, GSR, GPX1, GSTM1 and GSTM4 and CAT). Enzyme assays and total 
antioxidant activity were evaluated by different colorimetric assays on a 
microplate reader, while the reduced glutathione and lipid peroxidation were 
evaluated by fluorimetry. 
It was observed (for both exposure periods) that the highest concentration of 
SFN reduced cell viability relatively to control, and reduced the activity of all 
tested enzymes. The total antioxidant activity increased with time and 
decreased with the concentration of SFN. The activity of enzymes decreased 
with the increasing concentration of SFN (and with time for the highest SFN 
concentrations). There was also an increase of the reduced glutathione for low 
SFN concentrations, while it decreased for higher concentrations of SFN. 
Overall, the gene expression is consistent with the corresponding enzymes 
activities, i.e., the expression decreased with increasing concentrations of SFN.  
However, SOD was an exception (SOD activity decreased with SFN 
concentration whereas its expression increased).  
It can be observed that lipid peroxidation declined with SFN concentration 
increase. 
Finally, these results indicate that SFN induces oxidative stress in human 
osteosarcoma cells. It is proposed a model for the pathways involved in this 
oxidative stress–induced by SFN in osteosarcoma. 
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Introduction  
1. Osteosarcoma 
1.1. General considerations about cancer development and cell physiology  
In Europe, it is estimated that around 3.2 million new cases of cancer are diagnosed every 
year, with predominance of breast, colorectal, prostate and lung cancer occurrences 
(http://ec.europa.eu/healtheu/health_problems/cancer/index_pt.htm). Moreover, cancer is the second 
leading cause of death in the United States where it was estimated that, in 2007, over 1.4 
million people were diagnosed with cancer.  
Cancer is a highly heterogeneous and complex genetic disease since, according to the 
established model of oncogenesis, the occurrence of consequential mutations in coding 
regions of oncogenes and tumor suppressor genes is necessary, (un)regulating fundamental 
cellular processes like cell proliferation, differentiation and apoptosis for cancer 
development.  
The conversion of normal into cancer cells implies a progressive transformation into 
malignancy by multiple and sequential processes. These imply several alterations in 
cellular physiology such as high rates of proliferation and angiogenesis (Scholzová et al, 
2007; Cuezva et al, 2009).  
Diverse studies support that cancer results from disruptions of cell growth and death 
regulation pathways, which are maintained by the coordinated function of protein-coding 
genes (e.g. Mannoor et al, 2012). Genetic changes, such as DNA sequence alterations 
and/or chromosomal changes (e.g. structural or numerical changes) may lead to production 
of functionally aberrant protein, which may be at the basis of cell transformation into a 
cancer cell type. Besides DNA sequence alterations, the cell's microenvironment and other 
epigenetic events may also affect gene expression and thus quantitatively inﬂuence the 
level of ‘physiological’ protein(s) important in the regulation of cancer (Scholzová et al, 
2007; Cuezva et al, 2009). Up to moment, in all these scenarios (m)RNA has been 
regarded as a ‘passive’ intermediate but, in the last decade, some evidences suggest that 
different types of RNA molecules play important roles in gene regulation not only at the 
level of mRNA processing and regulation of mRNA stability but also at the level of gene 
transcription (e.g. Scholzová et al, 2007). 
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In this regard, many studies that were only focused on the analysis of genetic alterations 
are being questioned due to their limited applicability for the development of effective 
therapies. On the contrary, it is being now stressed the necessity to develop effective 
therapies against cancer based on targeting of the biological pathways commonly altered in 
the cancer cell (Cuezva et al, 2009).  Thus, it is fundamental to understand the cell 
pathways related with tumorigenesis. This knowledge will allow the development of cell 
molecular markers, which may contribute not only to early tumor detection methods 
(Mannoor et al, 2012) but also to improve the efficacy of existing therapies such as 
chemotherapy, etc. 
 
1.2. Osteosarcoma main characteristics 
Sarcomas are “a very heterogeneous group of malignant neoplasms of connective tissues, 
including bone and soft-tissues” (vide Demetri, 2012). This type of cancer is rare in 
comparison with carcinomas and have highest incidence during childhood or infancy (e.g. 
Kim et al, 2011).  
Most primary tumors of the skeleton depend on three varieties of spindle cells: those 
derived from the fibrous matrix designated by fibrosarcomas, the chondrosarcomas from 
cartilage and osteosarcomas (OS) that arise from bone (Majó et al, 2010). OS are the most 
frequent tumor of bone and are highly malignant. OS fundamental characteristic is that 
they develop from the stem cells that originate normal bone (Majó et al, 2010).  
OS are more frequent in younger-aged individuals (Trieb and Kotz, 2001). Its incidence is 
more notorious in individuals aged 11-20 years, and although it occurs with lower 
frequency in people aged 60-80, this incidence in younger-aged individuals coincides with 
the acceleration of bone growth (Kim et al, 2011).  
Considering the critical ages and also the lack of effective therapy it is necessary to 
improve the current research and therapies of this cancer type. Treatment usually includes 
both chemotherapy and surgery, since chemotherapy alone is incapable of eradicating the 
primary tumor (Majó et al, 2010).  
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1.3 . Osteoblast/osteosarcoma cell lines used in in vitro studies: emphasis on 
MG-63 
There are several OS cell lines available for in vitro studies (e.g. Table 1). The most 
commonly used are MG-63 and Saos-2 (Mohseny et al, 2011). The MG-63 cell line (used 
in this work) has typical fibroblasts-like morphology and grows as an adherent monolayer. 
These cells exhibit a number of characteristics typical of the osteoblast undifferentiated 
phenotype, including the expression of collagen type I and III, and a low basal expression 
of alkaline phosphatase (Pautke et al, 2004). Main advantages of the MG-63 cell line rely 
on their ease of culturing, so providing high amounts of cell material to perform a large 
number of biochemical and molecular studies related with factors that regulate metabolism 
of osteoblasts (Bilbe et al, 1996). 
 
Table I: Osteosarcoma cell lines.  Osteosarcoma subtype of the original tumor from which cells were derived, 
N/A- subtype information is not available for cell line. Cells were provided by the different partner institutes 
of the EuroBoNet network 21–25 or derived from ATCC (from Mohseny et al, 2011). For references marked 
with * see Mohseny et al, 2011.  
 
   
 
 
 
 
 
 
 
 
 
 
 
 
* 
* 
* 
* 
* 
* 
* 
* 
* 
* 
* 
* 
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2. Isothiocyanates  
2.1. Metabolism and bioactivity 
Isothiocyanates are compounds already described in literature for some tumor types as 
possessing potential antitumoral activity (e.g. Clarke et al, 2008; Traka and Mithen, 2009; 
Brown and Hampton, 2011; Yao et al, 2011). Isothiocyanates are a family of biologically 
active phytochemicals, which are derived from glucosinolate precursors (Dinkova-
Kostova, 2012).  
Glucosinolates (S- thioglucoside N-hydroxysulfates) are mainly found in cruciferous 
plants. There are almost 350 genera and 3000 species of Cruciferae or Brassicaceae family. 
The best-known species of Brassicaceae are the (commonly known) broccoli, cauliflower, 
cabbage, kale, brussels sprouts, radish and various mustards (Vasanthi et al, 2009).  These 
species are also known for their richness in bioactive products such as vitamins E, B1 and 
C, minerals like selenium, flavonoids like quercetin and carotenoids, and, the 
glucosinolates (Vasanthi et al, 2009). These last are among the most studied bioactive 
phytocompounds for antitumor properties.  
Glucosinolates are anionic, hydrophilic and sulfur-containing secondary metabolites 
(Zhang et al, 2011; Dinkova-Kostova, 2012). In all glucosinolate-containing plants, the β-
thioglucosidase enzymes known as myrosinases are also found, but located in different cell 
compartments: glucosinolates are found in vacuoles (Zhang et al, 2011) and myrosinases 
are found in, e.g. idioblasts. When tissues and cells are damaged, glucosinolates are 
hydrolysed by myrosinase released and form different products, such as isothiocyanates 
(ITCs), thiocyanates and nitriles, depending on the reaction conditions (Zhang et al, 2011; 
Dinkova-Kostova, 2012).  
The hydrolysis reaction consists on cleavage of thioglycoside by myrosinase enzyme, 
which releases glucose and forms an unstable non sugar compound named aglycone (R-C(-
SH)=N-O-SO3-) (Figure 1). After the formation of this intermediate compound the 
fragments of aglycone eliminate the sulfate group (SO4
2-
) giving rise to isothiocyanates 
group (R-N=C=S (Figure 1). Besides this product, other compounds are formed after the 
glucosinolates breakdown, such as thiocyanates and nitriles, etc. The formation of these 
compounds depends on the reaction conditions (e.g. pH, presence of Fe
2+
, or temperature) 
(Zhang et al, 2011; Guerrero-Beltrán et al, 2012). These compounds have bactericidal, 
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antioxidant, anticarcinogenic effects among others, while intact glucosinolates are believed 
to be inactive (Zhang et al, 2011). 
 
Figure 1: Glucosinolates hydrolysis (from Guerrero-Beltrán et al, 2012). 
 
After the hydrolysis reaction during digestion, isothiocyanates and other products of 
glucosinolate’s hydrolysis (e.g. thiocyanates and nitriles) are released into the intestinal 
lumen. Some of these products are not adsorbed and may be digested by the intestinal 
flora. On other hand, a substantial proportion of free isothiocyanates passively diffuses to 
the intestinal epithelial cells. These isothiocyanates are then conjugated with thiols, such as 
the reduced form of glutathione (GSH) (Dinkova-Kostova, 2012). After being conjugated 
with GSH, a reaction catalyzed by glutathione S-transferase (GST), the isothiocyanates 
become ready to interact with target tissues, which represents the ﬁrst step in the 
metabolism of isothiocyanates in biological systems (Dinkova-Kostova, 2012). 
As reported above, the isothiocyanates are characterized by high chemical reactivity in 
contrast to their relatively inert precursors. The central carbon atom of the isothiocyanate 
group (–N=C=S) is highly electrophilic and reacts avidly with sulfur-, nitrogen-, and 
oxygen-centered nucleophiles. As such nucleophiles are integral components of 
aminoacids it is not surprising that proteins and peptides are major cellular targets of 
isothiocyanates (Dinkova-Kostova, 2012). Furthermore, isothiocyanates have the capacity 
of react with sulfhydryls groups, which is useful for modification of proteins. 
Isothiocyanates ability to target the cystein residues existent in the proteins that control key 
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regulatory pathways leading to cancer has been suggested as being a possible mechanism 
by which these compounds show anticarcinogenic properties (Zhang and Hannink, 2003).  
The isothiocyanates can be divided into different phytochemicals based on their biological 
activities such as allyl isothiocyanate, benzyl isothiocyanate, phenethyl isothiocyanate, 
iberin and sulforaphane (SFN) (Yao et al, 2011) (Figure 2).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2: Isothiocyanates chemical structures which have been shown to protect against tumor development 
(from Dinkova-Kostova, 2012).  
  
In 1992, SFN was first identified as an excellent chemopreventive agent and several 
studies, regarding the mechanisms of action of this and of other isothiocyanates, were 
performed. Results show that these compounds induce different responses depending on 
the stage of carcinogenesis (Clarke et al, 2008). SFN has also the noteworthy capacity of 
acting in the three phases of the carcinogenic process: tumor initiation, promotion and 
progression and even in the last steps (angiogenesis and metastasis) (Traka and Mithen, 
2009).  
Other biological functions of isothiocyanates include their ability to: selectively degrade 
tubulin (a stable protein that is abundant in the cytoskeleton and is required for cell cycle 
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progression); induce apoptosis by having a pro-apoptotic activity (Brown and Hampton, 
2011; Yao et al, 2011).  
As result of the increasing knowledge about the bioactive properties of SFN and 
isothiocyanates in general, various authors highlight the importance of integrating 
isothiocyanate-rich crops on the daily diet (e.g. Bonnesen et al, 2001; Brigeuus-Flohe and 
Banning, 2006). Below we´ll explore some bioactive properties of the particular 
isothiocyanate, SFN.  
 
2.2. Sulforaphane (SFN) and bioactivity: focus on oxidative stress 
Sulforaphane (SFN), or 1-isothiocyanato-4 (methylsulﬁnyl) butane, is a compound 
belonging to the isothiocyanates family (mustard oils), as mentioned above (Naumann et 
al, 2011). This compound derives from glucoraphanin [methyl 4 - sulfinyl - butyl 
glucosinolate] and is one of the most widely studied isothiocyanates (Shan et al, 2006) 
(Figure 3). Glucoraphanin is the glucosinolate that by myrosinase (present in plant or in 
our intestinal flora) activity originates SFN (Clarke et al, 2008; Naumann et al, 2011). It is 
abundant in broccoli, cauliﬂower, cabbage, and kale with the highest concentration found 
in broccoli (Shan et al, 2006; Clarke et al, 2008). 
 
 
 
 
 
 
 
 
 
 
 
Figure 3: Structures of (A) glucoraphanin and (B) SFN (isothiocyanate hydrolysis product) (from Clarke et 
al, 2008). 
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As reported above for isothiocyanates in general, SFN is reported as having high potential 
as a cancer protective agent, since it reduces the generation of carcinogenic metabolites 
from consumed xenobiotics (Clarke et al, 2008; Naumann et al, 2011). In line with the 
previously described, several epidemiological studies have associated the consumption of 
cruciferous vegetables with a reduced risk of cancer (e.g. Levi et al, 2001; Naumann et al, 
2011).  
SFN was reported to have anticancer properties being most of the supporting studies 
performed with in vivo animal models (e.g. mice), and some clinical trials for e.g. breast 
and prostate cancer are ongoing (e.g. http://clinicaltrials.gov/). Recently, some in vitro 
studies testing SFN anti-tumor properties were published (e.g. Fimognari C et al, 2002; 
Jiang H et al, 2010; Sharma C et al, 2011). However, the in vitro experiments of SFN using 
OS cell lines remain residual (e.g. Kim M et al, 2011). Nevertheless, the use of in vitro 
studies may present several advantages to in vivo studies during the screening phases of 
specific compounds.  
Studies in animals indicated that SFN has chemopreventive activity against many 
carcinogens (Shan et al, 2006; Clarke et al, 2008). Other experiments in vivo demonstrated 
anticancer activity of SFN, e.g. when this compound is orally supplied, it leads to 
inhibition/retardation of experimental multistage carcinogenesis models including diverse 
type of cancers such breast, colon, stomach and lung (Priya et al, 2011; Chen et al, 2012). 
SFN has been described as inhibitor of histone deacetylase in vivo and suppressor of 
tumorigenesis in Apc
min
 mice (Myzak et al, 2006). In vivo studies were also performed to 
evaluate if a specific combination therapy would reduce tumor size in a synergistic 
manner, and the results supported that SFN may be suitable to increase targeting of 
pancreatic cancer stem cells by Sorafenib (Rausch et al, 2010). A recent in vivo study 
suggests that mice treated with SFN have an inhibition of tumor. SFN extract also reduces 
the appearance of tumors, the expression of survivin and induce caspase 3 and cytochrome 
c. Moreover, SFN extract retards the growth of UM-UC-3 xenografts in vivo, confirming 
its future potential in bladder cancer therapy (Wang and Shan, 2012).  
The interest in this agent has grown in the last years based on its beneﬁcial 
pharmacological potential, which includes antitumor activity as mentioned before, 
antioxidant and anti-inﬂammatory properties. For example, recently some data support that 
SFN induced oxidative stress on cancer cells by direct or indirect mechanisms (e.g. 
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Benedict et al 2012). However, its effect on oxidative status of the cell still remains unclear 
as the effects depend on the dose and cell type. Moreover, SFN also seems to protect other 
cells (normal cells) from oxidative stress induced from pro-oxidants (Zachichelli et al, 
2012). 
It has been proposed that SFN chemopreventive activity results in increased detoxification 
of xenobiotics and carcinogens (Topè et al, 2009; Qazi et al, 2010; Chen et al, 2012).  
A metabolism similar to the classical xenobiotic metabolism is reported to play a key role 
in tumor initiation process. Conventionally it is developed by two consecutive processes, 
controlled by phase I and phase II enzymes. Phase I enzymes convert pro-carcinogens into 
proximate or ultimate carcinogens, while phase II enzymes (e.g. GST) detoxify 
carcinogens and therefore facilitate their excretion from the body (Clark et al, 2008). This 
activity has been well studied and reveals diverse responses depending on the stage and the 
target tissue of carcinogenesis (Clarke et al, 2008). It has been proposed for some cancers 
that SFN modulates the carcinogenic process through: (a) blocking initiation via inhibiting 
Phase I enzymes, (b) inducing Phase II enzymes (Clarke et al, 2008), (c) activating 
antioxidant functions through an increase in GSH levels, (d) inducing apoptosis and 
inducing cell cycle arrest, (f) initiating anti-inflammatory properties and (g) inhibiting 
angiogenesis (Juge et al, 2007; Qazi et al, 2010).  
The properties mentioned before show that SFN is not only an important chemopreventive 
agent capable of inhibiting various stages of the carcinogenic process, but also has 
therapeutic potentially (Zhang, 2002) (Figure 4). 
 
Figure 4: Mechanism of action of SFN in the carcinogenic process, affecting the three phases of tumor 
initiation and the final stages of carcinogenesis (from Juge et al, 2007). 
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Consequently, SFN may regulate the metabolism of phase I enzymes by direct interaction 
with cytochrome P450 (CYP) or indirectly, by regulating the transcriptional levels of this 
enzymes in the cell. A clear example of phase I enzyme activity regulated by SFN is the 
reported inhibition of enzymes CYP1A1 and CYP2A2 activities, in breast tumor cells 
(Skupinskz et al, 2009). SFN was also described as the most potent natural inducer of 
phase II enzymes in animals and in humans (Talalay, 2000). 
SFN is not an antioxidant with direct action but there is substantial evidence that it acts 
indirectly to increase the antioxidant capacity of animal cells and their capacity to deal 
with oxidative stress (Fahey and Talalay, 1999) (Figure 5). However, other studies showed 
that SFN has the ability to increase intracellular ROS levels (Lee et al, 2012). Therefore, 
the effects of SFN in the oxidative status remain contradictory, depending on complex 
action mechanisms in cells and most probably depend on the cell type, dose, and the status 
of the cell.  
SFN was also demonstrated to promote apoptosis in some tumor cells. Recently, the 
induction of apoptosis in human monocytic U937 cells by SNF was demonstrated to be 
correlated with the generation of intracellular ROS as well as with the loss of 
mitochondrial membrane potential. This suggests that this pro-oxidant function can play a 
crucial role in SFN-induced apoptosis (Lee et al, 2012). 
Apoptosis plays an important role in the development and maintenance of homeostasis and 
also in the elimination of cells that are damaged or that are no longer needed to the body. 
The inappropriate regulation of this mechanism has been implicated in a wide variety of 
diseases, including cancer. Moreover, the induction of apoptosis may represent a safety 
mechanism by which several phytocompounds, including SFN, may inhibit such cellular 
disorders (Elbarbry and Elrody, 2011). The apoptotic process can be executed by the 
caspases cascade, cysteine proteases that are responsible for the initiation and execution of 
apoptosis (De Flora et al, 2001) (Figure 5). In this context it has been proposed that SFN is 
an inducer of apoptosis in several tumor lines such as bladder (Shan et al, 2006), ovary 
(Bryant et al, 2010), colon (Gamet-Payrastrem et al, 2000) and brain (Van Meir et al, 
2010). SFN also induce apoptosis in a dose-dependent manner in osteosarcoma tumor lines 
such as in murine LM8 cell line (Matsui et al, 2007) and in human osteosarcoma U2-OS 
(Kim et al, 2011).  
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There is diverse evidence that SFN may stop the cell cycle at several stages of its 
progression, leading to inhibition of cancer cells proliferation (Elbarbry and Elrody, 2011). 
The progression of the cell cycle is regulated by cyclin-dependent kinase (CDK) and 
cyclins (Juge et al, 2007) (Figure 5). Cell cycle arrest in the G2/M phase induced by SFN 
was observed in Jurkat T tumor cells (Fimognari et al, 2002) and in breast tumor cells 
(Jackson and Singletary, 2004), while in bladder carcinoma cells a cell cycle arrest in the 
G0/G1 phase was observed (Shan et al, 2006).  
 
 
 
 
 
 
 
 
 
 
 
  
Figure 5: Action mechanisms of chemoprevention by SFN leading to alteration in cell cycle arrest, apoptosis 
and/or growth inhibition (from Clarke et al, 2008). 
 
SFN interferes with diverse tumors such as human hepatoma HepG2 cells, which cause 
apoptosis at higher concentrations. However, at low concentrations SFN increases 
antioxidant defenses, via Nrf2-mediated gene expression (Lee et al, 2012). In prostate 
cancer PC-3 human cells, SFN inhibits cell growth, which is suggested to be linked with 
the activation of Erk and JNK signaling (Lee et al, 2012). 
Other mechanisms have been reported associated with SFN, such as eﬀects on NFκB 
transcription factors, inhibition of cyclooxygenase 2 (COX-2), eﬀects on protein kinases, 
and inhibition of histone deacetylase and of tubulin polymerization. So, SFN can act in 
several cell pathways (Shan et al, 2006; Chen et al, 2012). 
Considering the effects of SFN in inducing apoptosis and cell cycle blockage in 
osteosarcoma cells, few data are available, except for the in vitro studies of Kim et al 
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(2011), and those of our group where we have recently demonstrated in vitro that SFN also 
induces apoptosis and blocks cell cycle (in G2/M phase transition) in MG-63 cells (Costa 
et al 2012). 
 
  
3. Oxidative Stress and Free Radicals 
Some emerging data on SFN effects on tumor cells report its interference with the 
oxidative status of the cell (e.g. Lee et al 2012).  
Oxidative stress has been defined as a disturbance in the balance between the production of 
oxidant species (free radicals) and antioxidant defenses (cellular oxidants and antioxidant 
enzymes) which may lead to tissue injury (Nathan et al, 2011). This disturbance may be 
originated from excessive exposure to environmental pollutants, ultraviolet light, or 
ionizing radiation (Keck and Finley, 2004). The conditions mentioned before can lead to 
an overload of the cells’s antioxidant system, resulting in oxidative damage to proteins and 
nucleic acids; so oxidative stress is an important contributor to cell/tissue damage. In 
humans, this may lead to initiation of cancer as well as other degenerative diseases (Keck 
and Finley, 2004; Nathan et al, 2011). 
Free radicals are any chemical species with independent existence that contain unpaired 
electrons (Halliwell and Gutterige, 1999). These electrons increase the chemical reactivity 
of an atom or molecule. The most common examples of free radicals are the hydroxyl 
radical (
•
OH), superoxide anion (
•
O2
-
), transition metals such as iron and copper and nitric 
oxide (
•
NO) (Halliwell and Gutterige, 1999). 
Free radicals are obtained from many biochemical processes in large amounts as an 
unavoidable by-product of these biochemical processes (Nathan et al, 2011). In addition, 
these species may be formed in the body in response to diverse causes such as 
electromagnetic and ionizing radiation (e.g. X-rays and gamma rays) from the environment 
or acquired directly as oxidizing pollutants such as ozone and nitrogen dioxide. At the 
physiological level they can be produced by metal-catalyzed reactions, by neutrophils and 
macrophages activation during inflammation and by mitochondria (Halliwell and 
Gutterige, 1999).  
Free radicals can be also produced by reduction of molecular oxygen during aerobic 
respiration yielding superoxide and hydroxyl radicals in the mitochondrial electron 
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transport chain; as by-products of metabolic processes such as oxidation of catecholamines 
and activation of the arachidonic acid cascade product electrons, which can reduce 
molecular oxygen to superoxide; in cytochrome P450 enzymes metabolism; in, e.g. 
vascular endothelium that produces nitric oxide; or in inflammatory cell activation. In 
addition, free radicals can be produced physiologically in response to environmental stress 
agents (Valko et al, 2006; Jomova and Valko , 2011). 
The presence of unpaired electrons in free radicals confers them a high reactivity, although 
this varies from radical to radical. As most molecules are not free radicals, the majority of 
reactions will involve non-radical species. Reactions of a radical with a non-radical (all 
biological macromolecules are possible targets) produce free radical chain reactions with 
the formation of new radicals, which in turn can react with further macromolecules. 
Important examples are lipid peroxidation and protein damage. Lipid peroxidation 
products [e.g. malondialdehyde (MDA), 4-hydroxynonenal (HNE)] are potent mutagens 
and have been reported as modulators of signal pathways related to proliferation and 
apoptosis, processes implicated in carcinogenesis (Matés et al, 2008). From interaction 
with free radicals, DNA may also suffer damages (see 3.2.1) (Valko et al, 2006; Jomova 
and Valko, 2011). 
In the presence of these species, if antioxidant defenses are deficient, oxidative stress may 
cause damages in a variety of tissues and the accumulation of these species in DNA, 
proteins and lipids play a key role in the development of several diseases, such as cancer, 
atherosclerosis, neurodegenerative diseases and diabetes (Halliwell and Whiteman, 2004; 
Nathan et al, 2011). As result of free radical generalized attack of cell components, the 
body has developed a complex antioxidant defense mechanism in order to protect body 
tissues (Nathan et al, 2011). 
 
3.1. Reactive oxygen species (ROS) 
ROS are species with highly reactive capacity, produced during normal metabolic 
processes: through enzymatic reactions (e.g. respiratory chain) or via non-enzymatic 
reactions. Examples of ROS are the superoxide anion (O2•
-
), hydrogen peroxide (H2O2), 
and hydroxyl radicals (OH
-
) (Clarke et al, 2008; Harvilchuck et al, 2009; Priya et al, 2011).  
The hydroxyl radical, which is considered the most potent oxidant known, has an 
extremely short half-life and the ability to attack most biological molecules, resulting in the 
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propagation of free radical chain reactions. This radical can be generated through a variety 
of mechanisms, such as those mentioned earlier in section 3 (Liochev et al, 2002; Valko et 
al, 2006).  
Superoxide anions are formed when oxygen accepts an electron. They can act as a 
reducing agent of iron complexes (e.g. cytochrome c) by the Waber-Weiss reaction and it 
is likely to be an important source of hydroxyl radicals and hydrogen peroxide (Liochev et 
al, 2002; Valko et al, 2006). 
At physiological levels, ROS may be considered as beneficial in chemotherapy and cancer 
apoptosis, but their role in carcinogenesis has also been proposed. They are produced at a 
low level by normal aerobic metabolism and play an important role in signaling pathways 
regulating cell proliferation, differentiation, and activation of transcription factors 
(Harvilchuck et al, 2009; Nathan et al, 2011; Priya et al, 2011). However these species, 
present in high levels may cause cellular damage that induce cell death and pathological 
conditions (Clarke et al, 2008; Harvilchuck et al, 2009). In the last case, when higher levels 
of ROS are present, this excess causes damage by oxidizing DNA, lipids, proteins, and 
cellular macromolecules as mentioned before (Smith-Pearson et al, 2008; Harvilchuck et 
al, 2009) (Figure 6).  
Figure 6: The mitochondria is implicated in the generation of reactive oxygen species (ROS). In most cells, 
the mitochondrial respiratory chain is recognized as the major site of ROS production in the form of 
superoxide, hydrogen peroxide and the hydroxyl free radical. Excessive ROS are deleterious for the cell, 
contributing to a variety of pathological processes (from Nadege et al, 2009).  
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Oxidative stress, as mentioned before, may result from the increase in ROS, however it 
may also arise through changes in superoxide dismutase or in other defense mechanisms 
against ROS (Harvilchuck et al, 2009). The antioxidant defense system is responsible for 
the balance of ROS as a beneficial substance and has the responsibility of reducing cellular 
ROS (Smith-Pearson et al, 2008). This system is composed by endogenous antioxidants, 
more precisely it is formed by enzymatic (superoxide dismutase - SOD; glutathione 
peroxidase - GPx; glutathione reductase - GRx; catalase - CAT and Peroxiredoxins - Prxs) 
and non-enzymatic defenses (glutathione - GSH and coenzyme Q10, CoQ10) (Smith-
Pearson et al, 2008; Priya et al, 2011). 
 
 
    3.1.1. ROS and Cancer 
The complex multi-sequence process of cell conversion from a healthy stage to pre-
cancerous and later cancer stages is also known as “initiation–promotion–progression”. 
This model is based on the equilibrium between cell proliferation and cell death (Waisberg 
et al, 2003). The first step, cell proliferation, is upregulated by protein p53, which plays a 
primordial role in this mechanism. This protein checks the DNA integrity during cell cycle 
(Oren, 2003), and triggers mechanisms of DNA repair, for instance to eliminate the 
oxidized DNA bases that cause mutations. However when the cell damage is too large, p53 
may activate cell death by apoptosis at the same time.  
The three stages of this model are characterized by multiple events occurring in cascade in 
the cell (Dreher and Junod, 1996). ROS can act in all these stages of carcinogenesis 
through modifications on transduction, cell signaling pathways, and/or on other cellular 
events. These species can interact with DNA in the initiation process, causing non-lethal 
mutation that can pass cell cycle checkpoints. However excess of oxidative stress can be 
cytotoxic and promote cell proliferation inducing tumor growth. Many tumor inducers 
have an inhibiting effect on cellular antioxidant defenses (Dreher and Junod, 1996). ROS 
can also promote abnormalities in growth factor receptors, changing Ca
2+
 homeostasis, 
leading to deregulation of many signaling pathways that control cell proliferation or 
apoptosis (Dreher and Junod, 1996).  
Furthermore, ROS also act in the last carcinogenic step, more precisely in tumor 
angiogenesis and may regulate tumor invasiveness by modulating the gene expression. The 
stage of tumor progression is characterized by accumulation of additional genetic damage, 
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leading to the transition of the cell from benign to malignant, involves cellular and 
molecular changes (Collins, 2000; Nelson and Melendez, 2004).  
 
3.2. Oxidative damage 
    3.2.1. DNA Damage 
Reactive oxygen species can react with almost every molecule in a cell. The hydroxyl 
radical, for instance, is known to react directly with all components of the DNA molecule 
causing damage to purine and pyrimidine bases and also the deoxyribose backbone 
(Dizdaroglu et al, 2002).  
Several studies related with cancer tissues refer free radical-mediated DNA damage. ROS-
induced DNA damage can involve single- or double stranded DNA breaks, purine, 
pyrimidine, or deoxyribose modifications, and DNA cross-links. DNA damage can result 
either in arrest or induction of transcription, induction of signal transduction pathways, 
replication errors and genomic instability, all eventually associated to carcinogenesis 
(Cooke et al, 2003). Permanent modification of genetic material represents the first step 
involved in mutagenesis, carcinogenesis and ageing.  
Mutations and altered expression in mitochondrial genes encoding for respiratory 
complexes and in the hypervariable regions of mtDNA were identified as good indicators of 
DNA damage in several cancers (Penta et al, 2001; Vives-Bauza et al, 2006). Several 
studies have also reported 8-hydroxyguanine (8-OH-G or 8-oxo-G) as a good biomarker 
for DNA oxidative damage as well a potential biomarker of carcinogenesis (Kasai et al, 
2001). Other methods for measuring oxidative DNA damage may involve for example, 
enzymatic digestion of DNA, the acidic hydrolysis of DNA and others (Collins, 2000). 
 
    3.2.2. Lipid peroxidation  
All cellular membranes are sensitive to oxidative attack namely those membranes that have 
polyunsaturated fatty acids (PUFA) in its composition. The process of lipid peroxidation is 
divided in three stages: initiation, propagation and termination (Marnett, 1999).   
The peroxyl radicals (ROO•), after formation, can be arranged via a cyclization reaction to 
endoperoxides with the final product of the peroxidation process being malondialdehyde 
(MDA) (Marnett, 1999). This product is mutagenic in bacterial and mammalian cells and 
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carcinogenic in rats (Mao et al, 1999). Other major aldehyde product resulting from lipid 
peroxidation is 4-hydroxy-2-nonenal (HNE) which, unlike the weakly mutagenic MDA, is 
the major toxic product of lipid peroxidation and it also has a powerful effect on signal 
transduction pathways (Mao et al, 1999). MDA may interact with DNA, creating adducts 
that can lead to DNA–DNA inter-strand crosslinks or DNA–protein crosslinks (Mao et al, 
1999). All of these modifications can be deleterious to cells either being genotoxic and/or 
carcinogenic (Valko M et al, 2006). 
 
    3.2.3. Protein Oxidation 
Proteins can also be a target for ROS oxidation. Protein oxidation in vivo occurs in the 
presence of transition metals capable of entering in Fenton reactions (see equation 1, where 
M
n+
 is a metal). Examples of such transition metals include M
n+
 are Fe, Cu or Cr. Although 
other metals can catalyze this reaction, these are the most prevalent catalyzers. 
 
               
(   )          
 
Metal-catalyzed damages of proteins involve oxidative scission, loss of histidine residues, 
bityrosine crosslinks and introduction of carbonyl groups (Valko et al, 2007). 
The hydroxyl radical is one of the ROS that have the capacity to interfere with proteins, 
since they have the ability to remove from the protein polypeptide backbone the hydrogen 
atom forming a carbon centered radical, which can readily react with molecular oxygen to 
form peroxyl radicals (Stadtman, 1990). Protein damage is likely to be repairable and is a 
known non-lethal event for a cell.  
The action of ROS/RNS and ionizing radiation can affect the side chains of all amino acid 
residues of proteins. However, proline, histidine, arginine, lysine and cysteine residues are 
sensitive to oxidation by redox metals and may be preferable protein sites of metal binding. 
This protein-iron complex can react with H2O2, forming hydroxyl radical on site which can 
rapidly promote oxidation process (Stadtman, 2004). 
Proteins can also be attacked by nitrosylation reactions. The reaction of nitric oxide with 
superoxide radical results in the formation of the highly toxic peroxinitrite anion which can 
nitrosate cystein, nitrate tyrosine and tryptophan and oxidize methionine to methionine 
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sulphoxide. However, physiological concentration of carbon dioxide, strongly inhibit the 
process of modification of proteins by peroxynitrite. Even though the nitration of tyrosine 
is an irreversible process and can interact in phosphorylation and adenylylation process 
which are important in regulatory pathways (Valko et al, 2006).  
The accumulation of oxidized proteins in living systems can be induced by several factors 
acting alone or in combination. As consequence of these protein-ROS interactions, inter- 
and intra-protein cross-linkages occur. Therefore, protein carbonyl groups are generated. 
The concentration of these groups is considered a good biomarker of ROS mediated 
protein oxidation (Valko et al, 2006). 
 
3.3. Antioxidant systems  
Antioxidant is any substance that when present at low concentrations (compared with those 
of the oxidizable substrate) considerably delays or inhibits its oxidation (Betteridge, 2000).  
 The antioxidant system used by the cells can be categorized as enzymatic, non-enzymatic 
and extracellular mechanisms. The enzymatic defense is mediated by a group of enzymes 
which are capable of metabolize ROS and ROS precursors (e.g. H2O2). Non-enzymatic 
defenses include several molecules that can donate electrons to radical species or by 
processes that diminish ROS production (Betteridge, 2000; Kim et al, 2010).  
 
    3.3.1. Enzymatic Defenses 
Antioxidant enzymes are an important component of the antioxidant defense mechanisms 
(Priya et al, 2011). Cellular antioxidant defenses enzymes include the superoxide 
dismutase (SOD), glutathione peroxidase (GPx), catalase (CAT) and glutathione reductase 
(Betteridge, 2000). These enzymes act sequentially to achieve the scavenging of free 
radicals. Antioxidant defense is also formed by non-enzymatic defenses such as 
glutathione (Betteridge, 2000) (Figure 7).   
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Figure 7: Antioxidant enzyme system. The SODs convert superoxide radical into hydrogen peroxide. The 
CATs and GPxs convert hydrogen peroxide into water. In this way superoxide radical and hydrogen 
peroxide, are converted into the harmless product water. GPx requires several secondary enzymes (GR and 
G-6-PDH) and cofactors (GSH, NADPH, and glucose 6-phosphate) to function (from Li et al, 2000). 
 
Superoxide dismutase (SOD) has the capacity to delay or prevent damage from ROS.  
There are two SOD isoforms that are differently distributed among intra and extra cellular 
spaces. The Manganese-containing SOD (MnSOD) located in the mitochondria and 
Copper/Zinc-containing SOD (Cu/ZnSOD) found in the cytosol. These isoenzymes are 
capable of catalyzing the dismutation of superoxide anion to hydrogen peroxide and 
molecular oxygen (equation 2) (Betteridge, 2000; Zelko et al, 2002; Vurusaner et al, 2012). 
 
         
     
   
→            
 
H2O2 is a weaker oxidant and can act as an intracellular and extracellular signaling 
molecule (Betteridge, 2000; Clarke et al, 2008; Harvilchuck et al, 2009). This molecule 
can react with transition metals (Cu
+
, Fe
2+
) via Fenton reaction when they are in low levels, 
leading to the formation of deleterious hydroxyl radical, another reactive specie (Kim et al, 
2010). 
Hydrogen peroxide generated by the reaction controlled by SOD can be reduced by two 
enzyme systems, glutathione peroxidase (GPx) and catalase (CAT).  The first, depending 
on the protein isoforms, is present in cytosol and in mitochondria (Betteridge, 2000). There 
are multiple GPx proteins, and at least two different types are present in most human 
tissues. One GPx form contains selenium in its active center (selenium-dependent: Se-
GPx) and the other is a cationic isoenzyme of glutathione S-transferases which is 
selenium-independent (t-GPx) (Saydam et al, 1997). 
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Hydrogen peroxide reduction by GPx requires reduced glutathione (GSH) generating H2O 
and oxidized glutathione (GSSG) (Peskin and Winterbourn, 2000) as illustrated by 
equation 3. 
               
   
→           
 
CAT can also breakdown H2O2 in many tissues decomposing it to water and oxygen. It is 
localized in peroxisomes and is the primary component of the antioxidant system 
(Betteridge, 2000).  CAT is mostly responsible for the removal of H2O2 when it is present 
in higher concentration in tissue (equation 4) (Aebi, 1984). 
 
         
   
→          
 
Glutathione reductase (GRx) is a homodimeric ﬂavoprotein that catalyzes the reduction of 
glutathione disulfide (GSSG - oxidized glutathione) produced by the reaction of GPx, to 
form sulfhydryl GSH (reduced glutathione, important cellular antioxidant) in the presence 
of NADPH as a reducing cofactor. This enzyme is necessary for the functioning of GPx 
(Saydam et al, 1997; Kim et al, 2010).  
When these enzymatic systems work together, they efficiently maintain the oxidant species 
balance in cells and tissues. 
 
    3.3.2. Non-enzymatic defenses  
The antioxidant system is also formed by non-enzymatic defenses. These non-enzymatic 
molecules act as antioxidants and can control oxidative stress. Some examples of these 
defenses are molecules such as vitamin E, coenzyme Q, β-carotene and other carotenes 
present within cell membranes, other examples are vitamin C (L-ascorbic acid) and 
glutathione (-L-glutamyl-L-cysteinylglycine) mostly present in cytosol (Ascenso et al, 
2011). Glutathione is the major metabolite involved in determining cellular redox state and 
functions in the cellular thiol/disulﬁde system (Yang et al, 2006; Vurusaner et al, 2012). 
Glutathione is a small tripeptide which is the principal cellular antioxidant present 
primarily in the reduced form (GSH) (Yang et al, 2006; Kim et al, 2010). This molecule is 
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involved in the conjugation and detoxiﬁcation of numerous types of compounds that cause 
toxicity and carcinogenesis (Kim et al, 2010). Under stable state conditions, the ratio 
GSH/GSSG is maintained. When excessive oxidation occurs in the cell, the GSH/GSSG 
ratio decreases, affecting other cellular events such as cell signaling and apoptosis, cellular 
growth and differentiation. This decrease has been reported to putatively promote tumor 
development through a mechanism that involves cytotoxicity (Yang et al, 2006).  
Besides the molecules mentioned above, tissues are also protected against free radicals by 
several binding proteins (transferrin, lactoferrin, ceruloplasmin, haptoglobins, hemopexin 
and albumin) which can sequester metals and keep them in a nonreactive state (Valko et al, 
2006). Indeed the mechanism of metal-induced free radicals formation is tightly influenced 
by the action of cellular antioxidants. These proteins are highly inducible by metals and 
oxidants and thus, are critical in protection against exogenous oxidants (Qiang, 2010). 
Moreover, many low-molecular weight antioxidants such as ascorbic acid, alpha-
tocopherol, glutathione (GSH), carotenoids, flavonoids, and other antioxidants, are capable 
of chelating metal ions reducing thus their catalytic activity to form ROS (Jomova and 
Valko, 2011). 
 
    3.3.3. Others Defenses 
Besides the above reported antioxidant systems (enzymatic and non-enzymatic systems), 
cells also have complementary mechanisms in order to regulate ROS production, namely 
the metabolic uncoupling of mitochondria. The short-cut of the mitochondrial electron 
chain by uncoupling proteins (UCP) decrease ROS formation where the reduction power of 
oxidative metabolism is transferred to health production and ROS-formation control 
(Qiang, 2010).  
 
4. SFN and Oxidative Stress  
Several studies have demonstrated that SFN may interfere with oxidative stress. Depending 
on the cell line or tissue, SFN may induce varying effects on antioxidant enzymes levels 
and activities, e.g. in some cases an increase is observed in some antioxidant enzymes and 
in other cases a decrease is observed (Jiang et al, 2003). 
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Mitochondrial fractions from pulmonary and hepatic tumors of mice are also affected by 
SFN, since they show a signiﬁcant increase in the activities of SOD, CAT, GPx and the 
redox cycle enzymes. In these tumors, a signiﬁcant increase in CAT and SOD activities is 
observed, associated with an increase in GSH levels (Priya et al, 2011). The increase of 
these antioxidant enzymes might have a potential role in the detoxiﬁcation and elimination 
of potential carcinogens present in the body, supporting the effects of SFN on this type of 
tumors (Priya et al, 2011). 
In another study, H-SY5Y cells (neuroblastoma) were treated with 2.5 and 5 µmol/L of 
SFN and did not show any signiﬁcant changes in SOD and CAT activities. However, the 
treatment of these cells with 5µmol/L SFN for 24 h induced significant increases of GR but 
not in GPx activities (Tarozzi et al, 2009).  
In PC-3 cells treated with 40µM of SFN for 6 h, the protein levels of Cu,Zn-SOD and Mn-
SOD were higher, especially for the latter, an increase in SOD activity was also observed. 
On the other hand, SFN treatment did not affect CAT activity neither protein levels in 
those cells (Singh et al, 2005). 
Yang and co-workers showed that mouse liver, different brain regions and other tissues 
express different antioxidant enzyme activities, which may result in different reactions to 
oxidative stress, depending on the tissue (Yang et al, 2006). An example is the GR activity 
which is inhibited consistently by SFN in diverse types of cell lines, such as Hepa1c1c7, 
HepG2, MCF7, MDA-MB-231, LNCaP, and HT-29 cells, while in other cell lines such as 
HeLa cells GR activity is induced by SFN (Jiang et al, 2003). GR is associated with several 
cellular mechanisms while maintaining a high ratio GSH/GSSG in the cell, such as protein 
and DNA biosynthesis and a defensive response against free radicals and ROS. If in some 
cells inhibition of GR occurs, this leads to an accumulation of GSSG, which generates a 
state of thiol oxidative stress (Kim et al, 2010). SFN has been described as a stabilizer of 
glutathione-metabolizing system under oxidative stress (Priya et al, 2011). 
In CaCo-2 cells treated with SFN it was observed an increase in GPx, which suggests that 
SFN induces GPx via Nrf2/Keap1 and leads to a decreased risk of developing 
gastrointestinal cancers (Banning et al, 2005; Brigeuus-Flohe and Banning, 2006). Figure 8 
shows the currently proposed mechanism of action of SFN via Nrf2/Keap1 (Boddupalli et 
al, 2012). 
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Figure 8: Mechanism of antioxidant response elements (ARE) mediated detoxifying and antioxidant enzyme 
induction by SFN. (A) Under basal conditions, the transcription factor NrF2 is sequestered within the cytosol 
by the repressor proteins Keap1 and cullin 3 (CUL3). SFN, through modiﬁcation of the highly redox-
sensitive cysteine residues of KEAP1, facilitates the dissociation of the Keap1/CUL3/NrF2 complex, 
releasing NrF2, which translocates into the nucleus. In the nucleus, NrF2 heterodimerically pairs with small 
Maf transcription factors binding to ARE contained within the promoter regions of many enzymes, initiating 
their transcription. (B) ARE-mediated gene products (antioxidant enzymes) (from Boddupalli et al, 2012). 
 
 
GSH is extremely important in the cell, a reduction in GSH levels (or increase in oxidized 
state) in the tissue has been associated with a number of human diseases including 
Alzheimer, Parkinson, liver disease, heart attack, diabetes, infection caused by HIV and 
cancer (Yang et al, 2009). Furthermore, a decrease in intracellular GSH levels is likely to 
occur due to exposure to toxicants, tissue or DNA damage (Yang et al, 2009). 
In SH-SY5Y cells, SFN enhances total GSH levels, when the cells are treated with 5 
µmol/L of SFN for 24h. In addition, the augmentation in cellular GSH levels induced for 
the second concentration, a treatment time-dependent relationship (Tarozzi et al, 2009). 
SFN also leads to the increase of cytosolic GSH levels possibly leading to a simultaneous 
elevation of the antioxidant enzymes in the mitochondria, avoiding the thiol oxidation of 
the complex I, an event responsible for mitochondrial dysfunction (Tarozzi et al, 2009).  
However, SFN had opposite effects in other cell lines: this compound is an electrophilic 
molecule capable of reacting with cellular nucleophiles such as GSH, therefore, SFN 
treatment might cause GSH depletion intensifying oxidative stress (Singh et al, 2005). An 
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example of this is in PC 3 cells where SFN provoked a rapid and significant depletion of 
GSH levels. This indicates that SFN induced ROS generation and this is probably mediated 
by a non-mitochondrial mechanism involving GSH depletion and a mitochondrial 
component (Singh et al, 2005). Also in this case, SFN action depends on the tissue and 
concentration.  
 
 
Objectives 
The main aim of the present dissertation was to evaluate if SFN induces oxidative stress in 
osteosarcoma cells. If so, other aims were proposed: a) what are the main 
enzymes/pathways affected by SFN (see Figure 7), and b) is this influence in the enzymes 
related with transcriptional or post transcriptional events. 
For the SFN in vitro studies the largely used osteosarcoma cell line (MG-63) was used. 
The SFN effects at the oxidative stress were evaluated on these cells for SOD, GR and 
GPx activities, GSH levels, lipid peroxidation, and total antioxidant activity. Finally to 
evaluate putative transcriptional/post-transcriptional effects gene expression for genes 
related with oxidative stress was also measured. These parameters were evaluated for 24 
and 48h of exposure to SFN (0, 5, 10 and 20µM).  
The study of antioxidant enzymes and related mechanisms will allow the elucidation of the 
response of deregulation mechanisms to oxidative stress. This information will contribute 
to better understand how SFN affects osteosarcoma cell metabolism, and may provide 
further information for the eventual use of this compound in osteosarcoma therapy. 
 
 
Material and Methods 
1. Cell Culture  
Human osteosarcoma MG-63 cell line, supplied by courtesy by the INEB (Instituto de 
Engenharia Biomédica-Porto, Portugal), was cultured in 75-cm
2
 standard culture flasks 
with -Minimum Essential Medium (α-MEM) (Life Technologies, Carlsbad, CA) 
supplemented with 10% (v/v) fetal bovine serum (FBS) (Life Technologies, Carlsbad, 
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CA), 2.5 µg/mL fungizone (Life Technologies, Carlsbad, CA) and 10000 U/mL penicillin-
streptomycin (Life Technologies, Carlsbad, CA).  Cells were observed with an inverted 
microscope (Olympus, Japan). When cultures reached approximately 80% confluence, 
cells were washed twice with Phosphate Buffer Saline without Ca
2+
/Mg
2+
 (PBS) (Life 
Technologies, Carlsbad, CA) and then incubated with trypsinized with Trypsin-EDTA 
solution (0.25% Trypsin, 1 mM EDTA) (Life Technologies, Carlsbad, CA) (3 mL/75 cm
2
) 
until the disaggregation of cells (2-5 min at 37 °C). When cells were completely detached, 
complete growth medium was added for trypsin deactivation. Subsequently, cells were 
resuspended and counted by using a hemocytometer. Afterwards, cells were seeded at 10
5
 
cell/mL in 10 mL of supplemented medium. After this procedure cells were incubated at 
37 °C in a 5% CO2 humidiﬁed atmosphere.  
 
1.1. SFN exposure  
D,L-sulforaphane (Sigma-Aldrich, St. Louis, MO) was dissolved in dimethyl sulfoxide  
(DMSO) (Sigma-Aldrich, St. Louis, MO) at a concentration of 10 mM and stored at -20 
ºC. For all assays, the exposure procedure was the following: Cells were seeded and 
allowed to adhere for 24 h, when cells reached 50-60% of confluence, the medium was 
removed and replaced by fresh medium containing 0, 5, 10, and 20 µM of SFN.  
The cultures were routinely visualized for confluence and cell morphology, in order to 
evaluate the possible effects of SFN. Cells were grown for 24 and 48 h (exposure time) and 
then harvested for each specific measurement. Depending on the particular assay, cells 
underwent slightly different seeding and harvesting methods. 
 
 2. Cell viability  
Cell viability was measured by the Trypan Blue assay. In order to observe the interaction 
of SFN on cell viability, cells were seeded in a 24-well plate at the concentration of 
10
5
 cells/mL and left for 24 h to adhere. Subsequently, cells were exposed to 0, 5, 10 and 
20 µM of SFN in growth medium during 24 and 48 h. After this period (24 or 48 h), the 
medium was removed, cells were washed with 200µL of PBS and then 76µL of trypsin 
were added. When cells were completely detached, growth medium was added for trypsin 
deactivation (231µL). Afterwards, 20µL of cell suspension were transferred to a microtube 
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and 20µL of trypan blue dye (TC10
TM
, Bio-Rad, Hercules, CA) were added. The mixture 
was incubated for 3 min at room temperature and 10µL were used to determine viability 
after cell counting in an automated counter (TC10
TM
, Bio-Rad, Hercules, CA).  
 
3.  Protein quantification  
Protein quantification was performed through Bradford assay, which is a colorimetric 
method based in the dye Coomassie Brilliant Blue G-250 (Bradford Reagent) (Sigma-
Aldrich, St. Louis, MO) binding to protein. This leads to an absorption peak shift from 465 
nm to 595 nm, in which the amount of absorption is proportional to the quantity of sample 
protein (Bradford MM, 1976).  
For this procedure, 5 μL of each sample extract, corresponding to different concentrations 
and times of exposure, were incubated with 250 μL of Bradford Reagent in the dark for 5 
min. The same procedure was applied for the standard curve, using known concentrations 
of bovine serum albumin (BSA) (Sigma-Aldrich St. Louis, US-MO) instead of sample. 
The absorbance was read at 595 nm in a microplate reader (Synergy HT Multi-Mode, 
BioTek®, VT, USA). The concentrations of unknown samples were calculated from 
standard curve.   
 
4. Enzymatic parameters 
For all enzyme assays, cells were seeded in 100-mm culture dishes (Corning®) and 
exposed to SFN as described above in 1.1. In order to obtain the homogenates for analyses, 
the method described by Quick (Quick, 2000) was followed with some modifications. 
Briefly, the culture medium was removed and cells were washed in 1 mL of PBS, after this 
addition cells was scraped. After this, cells were centrifuged at 1000g for 10 min at 4ºC 
and the supernatant was discarded. For most enzyme assays, the cell pellet was 
resuspended in 750µL of cold phosphate buffer (5 mM, pH 7.4) with 1 mM of EDTA. For 
the GPx enzyme assay, however, after centrifugation, the cell pellet was resuspended in 
350µL of cold phosphate buffer and then sonicated once for 30s over ice.  
Finally, to clear cellular debris, the homogenates were centrifuged at 12000g for 15 min at 
4 °C, and the supernatants were aliquoted to separate vials, one for protein quantification 
and the remaining vials for each enzyme assay. All samples were stored at -80 °C until 
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assayed. All enzyme reactions were performed in a 96-well plate, and the absorbance 
variation was read in a microplate reader (Synergy HT Multi-Mode, BioTek®, VT, USA).  
 
4.1. Superoxide Dismutase (SOD) 
SOD is the first line of defense against oxidative stress, namely by acting as a superoxide 
anion radical scavenger (Zelko  et al, 2002). At present, three distinct isoforms of SOD 
were identified in mammals, CuZn-SOD, Mn-SOD and EC-SOD which differ in their 
structure and location. SOD catalyzes the dismutation of superoxide anion O2
•- 
to 
molecular
 
oxygen and oxygen peroxide (H2O2).  
Total SOD activity was measured by using Sigma-Aldrich
®
 SOD-assay kit (Sigma-
Aldrich, St. Louis, US-MO) and the reaction was performed in accordance to kit 
instructions. In this system, xanthine oxidase (XO) will form superoxide anion and from 
this WST-1 will regenerate O2 forming a colored compound. SOD present in the sample 
will convert superoxide anion in H2O2 leading to colored product decrease.  
In this assay, 20 μL of sample were added to 200 μL of a buffer containing WST-1 (WST- 
Working solution). After this, 20 μL of XO solution were added to initiate the reaction. 
Absorbance variation was read in a microplate reader in kinetic mode at 440 nm for 5 min. 
The percentage of inhibition was calculated by the following equation: 
 
                         
(     )  (     )
(     )
     
 
The reaction was always performed with a “blank well” to calculate XO maximum rate 
(S1), this was formed by miliQ water, WST-Working Solution and Enzyme solution. The 
other “blank wells” were: a well without XO and sample (S3), a well with only with miliQ 
water and dilution buffer and other without XO (S2) formed by dilution buffer, WST-
working solution and sample. All results were normalized by sample protein concentration 
and one unit of SOD activity was considered as the enzyme amount which yields a 50% 
inhibition in WST-1 reduction.  
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4.2. Glutathione Peroxidase (GPx) 
GPx proteins are present as cytosolic, mitochondrial and extracellular enzymes and play a 
major role in the elimination of hydrogen peroxide (H2O2) generated by superoxide 
dismutase and other organic hydroperoxides (ROOH). 
In mammals, the GPx family includes at least five enzymes with different subcellular 
localizations. In humans, one of these isoforms, GPx1, contains selenium in its active 
center which is implicated in its catalysis. The other isoform is a cationic isoenzyme of 
glutathione S-transferases which is selenium-independent (t-GPx) (Halliwell, 1994) GPx 
uses as a reducing equivalent glutathione (GSH) which is recycled through GR reaction 
from its dimer form (GSSG) to the reduced one (GSH).  
The determination of GPx activity was performed as described by Smith and Levander, 
(2002) with some alterations.  
  
               
              
→                   
 
Briefly, after the procedure described in 4, 50µL of the sample were incubated for 10 min 
on a 96-well plate, in phosphate buffer (50 mM, pH 7.4 and 5 mM of EDTA) with 2 mM 
GSH, 1 mM sodium azide (Sigma-Aldrich, St. Louis, MO), NADPH 0.4 mM (Sigma-
Aldrich, St. Louis, MO) and 2mM GR, final concentrations The reaction was initiated by 
the addition of 10µL tert-butyl hydroperoxide solution (Sigma-Aldrich, St. Louis, MO). 
GPx activity was measured directly by the decay in absorbance of NADPH at 340 nm in a 
microplate reader. Sample activity was extrapolated using the equation below:  
 
 
       
(      s     minbg)  T 
  
 
 
Where ΔA/mins is the change in absorbance per minute for the sample; ΔA/minbg is the 
change in absorbance per minute for the blank; TV is the total volume of the assay (mL); ε 
is the extinction coefficient and d is the path length value calculated thought the equation:  
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      Path length  
       (  )
  (  )2
 
 
One enzyme unit of GPx activity is defined as 1 µmol of NADPH oxidized per minute at 
37°C.  Finally, the GPx specific activity was expressed as a ratio of its activity and the 
protein content of the samples. 
 
4.3. Glutathione Reductase (GR) 
GR plays an important role in cell antioxidant state by producing antioxidant species, this 
enzyme  catalyzes the reduction of glutathione disulfide (GSSG) produced by GPx activity, 
to the glutathione reduced form (GSH) using NADPH as its source of reducing 
equivalents. The reaction mentioned in the previous step (GPx activity) produces GSSG 
which is then recycled to GSH by GR as shown by the equation described below: 
 
                   
             
→                
 
GR activity was measured directly by the decay in absorbance of NADPH at 340 nm in a 
microplate reader accordingly to Dringen (Dringen and Gutterer, 2002) with some 
modifications. The reaction was carried in 100 mM phosphate buffer containing 1 mM 
EDTA, pH 7.4, at 25°C in a 96-well microplate. The reaction was started by the addition of 
GSSG solution in 1:1 to the mixture of NADPH and sample. The final concentrations were 
1 mM GSSG and 0.2 mM NADPH in a final volume of 320 μL. In parallel with sample 
measurements, a calibration curve was performed with standard GR to extrapolate sample 
activity. Finally, GR specific activity was calculated as enzyme activity per minute per 
protein content of the samples. 
 
4.4. Reduced Glutathione (GSH) quantification 
Glutathione is the key antioxidant in animal tissues. It is present in the cells mainly in the 
GSH reduced form. Intracellular GSH status serves as an indicator of the cell capacity to 
resist toxic challenge and also appears be a sensitive indicator of the overall health of a 
30 
 
cell. For GSH quantification, the Glutathione Assay Kit, Fluorimetric (Sigma-Aldrich, St. 
Louis, MO) was used. In this system, a thiol probe (monochlorobimane) which can freely 
pass through the plasma membrane is used and when it binds to reduced glutathione in a 
reaction catalyzed by glutathione S-transferase (GST), it forms a strongly fluorescent 
adduct that can be measured in a microplate reader. Briefly, cells were seeded in a 
fluorometric 96-well plate, in a density of 10
5 
cells/mL. After exposure periods the cells 
were washed with PBS, the kit reagents were added and finally read on microplate reader 
at 360nm excitation and 485nm emission. In parallel with sample measurement, a 
calibration curve was performed with GSH standard to extrapolate the sample activity.  
In order to normalize GSH levels, the protein amount was determined for each sample. 
After fluorometric reading, cells were washed with PBS, incubated with the Glutathione 
Assay Kit’s lysis buffer during 30min in shaker. After this, 5µL of homogenate were taken 
to a new well and 250µL of Bradford Reagent (Sigma-Aldrich, St. Louis, MO) were added. 
The plate remained in agitation in darkness for 10min and protein amounts were 
determined after this period. 
 
5. Total antioxidant activity (TAA) 
TAA was measured using the Antioxidant Assay KIT Sigma-Aldrich, St. Louis, MO). This 
assay is based on the capacity of antioxidant molecules in the samples to reduce ABTS 
(2,2´-azino-bis(3-ethylbenzthiazoline-6-sulfonic acid) to produce a radical cation, ABTS
•+
, 
a green soluble chromogen that can be determined spectrophotometrically at 405 nm in 
microplate reader.  
Cell homogenates were prepared in the same manner as in section 4 using the method 
described by Quick et al, 2000 with modifications. Cells were washed in 2 mL cold PBS, 
scraped on ice, and then centrifuged at 1000 g for 10 min at 4 ºC.  After this, the pellet was 
resuspended in assay buffer and sonicated for 30s. The homogenates were centrifuged at 
12000 g for 15 min at 4 °C, and the supernatants were stored at -80 ºC until further 
analysis. ABTS reaction and spectrophotometric measurements were according to the 
manufacturer’s instructions.  alues obtained for each sample were compared with the 
concentration-response curve of standard Trolox solutions. Absorbance values were 
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normalized to protein amount and expressed as micromoles of Trolox equivalent per 
milligram of protein.  
 
6. Thiobarbituric acid reactive species (TBARS) assay 
Lipid peroxidation analyses were performed by the TBARS assay Kit (Cayman, Michigan, 
USA) with small modifications to manufacturer instructions. Briefly, cells were seeded in 
150-mm culture dishes (Corning®) and exposed to SFN as described above in 1.1. The 
culture medium was removed and cells were washed first with 2 mL of PBS, then with 3-
mL cold PBS and after washing cells were scraped. Subsequently, cells were centrifuged at 
1000g for 10 min at 4ºC and the pellet was resuspended in 1mL of cold PBS. Next the 
suspension was sonicated for 30s over ice and 40µL of homogenate was removed for 
subsequent protein analysis.  To the remaining suspension and standards, TBA SDS 
solution was added and after this color reagent. Finally 3,5-di-tert-butyl-4-hydroxytoluene 
(BHT) (Sigma-Aldrich, St. Louis, MO) also was added, in order to decrease oxidation 
caused by the procedure. The homogenates were placed in a water-bath at 95ºC for 1h and 
immediately placed on ice for10min. Finally, the homogenates were centrifuged at 5000g 
for 10 min at 4 °C and the clear supernatant was stored for fluorometric analysis (530nm 
excitation, 550nm emission). Values obtained for each sample were compared with the 
concentration-response curve of standard solutions prepared with TBA Malondialdehyde 
standard. Fluorometric values were normalized with protein. 
 
7. Enzyme gene expression 
 7.1. RNA extraction and quantification  
  As preparation for RNase-free work, all bench surfaces, pipettes and material were 
sprayed with 0.1 mM NaOH/ 1mM EDTA solution, followed by DEPC-Water spray. All 
consumables used were sterilized in order to denaturate/inactivate RNases.   
For this assay 10
4
 cells per well were seeded in 12-well plates. Cells were cultured during 
24 h for adherence, and then exposed to SFN (control, 5 and 10µM) during 24 and 48 h. 
After that, cells were washed with PBS, and finally, collected with TRIzol reagent (Life 
Technologies, Carlsbad, CA). After this, 200 μL of chloroform were added (Merck, 
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Darmstadt, Germany) to each sample, the solution was shaken and centrifuged at 12000 g 
for 15 min at 4ºC for phase separation. The aqueous phase (top) containing RNA was 
collected. One volume of 70% ethanol (RNase-free) was added to the collected aqueous 
phase. From this point, a QIAGEN RNeasy Mini kit (Qiagen, Dusseldorf, Germany) was 
used for RNA extraction. All previous solutions were transferred to an RNeasy spin 
column and centrifuged for 15s at 8000g. Subsequently, the solution was washed and 
centrifuged successively with: 700 μL of RW1 buffer and twice with 500 μL of RPE buffer 
for 2 min. In all this steps the flow-through was discarded. The RW1 buffer is used as a 
stringent washing buffer that efficiently removes biomolecules such as carbohydrates, 
proteins, fatty acids, etc and RPE buffer is a mild washing buffer that is used to remove 
traces of salts, which are still on the column due to buffers used earlier in the protocol. 
Each spin column was then placed in a new RNase-free 1.5mL tube and 40 µL RNAse-free 
water were added directly to the spin column membrane, proceeding thereafter to 
centrifugation for 1 min at 8000g to elute the RNA (eluted water was applied again onto 
the column). Finally, the RNA quality and quantity was determined using NanoDrop 
(A260/280 ≥ 2-Pure RNA; A260/280 ~ 1.8-DNA contamination or ethanol; A260/230 << 
2-contamination with proteins, chaotropic salts like guanidinium isothiocyanate or phenol). 
RNAs should be:  >300 ng/uL; A260/280 ~2 or slightly higher; A260/A230 ~2.  
           
7.2. cDNA synthesis for qPCR  
For DNase I incubation, 2 ng of external transcript was added to 2 μg of total RNA in 
DEPC-treated H2O (8.0 μL final volume). Then, each diluted RNA sample was incubated 
at 37°C for 15 min with DNase I (DNase I - Amplification grade, Life Technologies, 
Carlsbad, CA) to a final 10 μL volume.  DNase I was inactivated according to the 
manufacturer’s instructions. 
For Reverse Transcription, the QIAGEN Omniscript kit (Qiagen, Duesseldorf, Germany) 
was used. The final RT mix with DNase-treated RNA contained 0.5 mM each 
deoxyribonucleotide phosphate (dNTPs), 4 µM Oligo dT18 and Omniscript RT Enzyme. 
The RT reaction was carried out at 37°C for 1 h. The synthesized cDNA was diluted 20x in 
milliQ H2O and stored at -20°C, until qPCR was performed. 
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7.3. qPCR 
For these analyses the iQ5 Bio-Rad thermal cycler (Bio-Rad, Hercules, CA) was used. 
First, the correct PCR program (cycles, temperatures etc), plate default, fluorochromes 
(e.g. SYBR green) was chosen. All reagents as well as 96-well PCR plate were kept on ice. 
The number of wells needed for the analysis was calculated based on the formula indicated 
below:  
 
     
[(No.biological samples   No.replicates)   ]  No.genes including reference genes  
 
The following qPCR primers were used: SOD1-F: GGTGTGGCCGATGTGTCTAT; 
SOD1-R: TTCCAGCGTTTCCTGTCTTT; SOD2-F: CCCTGGAACCTCACATCAAC; 
SOD2-R: CTGAAGAGCTATCTGGGCTGTAA; CAT-F: 
TGAACTGTCCCTACCGTGCT; CAT-R: TATTGGATGCTGTGCTCCAG; GPX1-F: 
CGGGACTACACCCAGATGAA; GPX1-R: TCTCTTCGTTCTTGGCGTTC; GSR-F: 
GATCCCAAGCCCACAATAGA; GSR-R: TCGCTGGTTATTCCTAAGCTG; 
GSTM_1_F: CAGAGCAACGCCATCTTGT; GSTM_1_R: 
GCCAGCTGCATATGGTTGT; GSTM_4_F: AGAGCAACGCCATCCTGT; 
GSTM_4_R: GATTGGAGACGTCCATAGCC. The final individual qPCR reactions 
contained SYBR green mixture (iQ 2x SYBR Green Supermix) (BioRad, Hercules, CA), 
1.5 uM each primer and cDNA. No Template Controls (NTC) were also performed in 
which milliQ water was added instead of cDNA. 
Each cDNA was pipetted into a specific reaction tube (per sample per gene) and then was 
added a specific volume (depends on number of reaction tubes), to which a pre-mix 
containing SYBR green and primers was added.  After mixing, technical duplicates (15 µL 
each) were taken to each well in the PCR plate. Moreover, 11.2 µL of reaction mixture 
(SYBR green and primer mix) and 3.8 µL milliQ water were transferred to individual wells 
as No Template Control. The plate was carefully sealed and placed on the iQ5 Bio-Rad 
thermal cycler (Bio-Rad, Hercules, CA) for start the run. 
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8. Data and Statistical Analysis  
For most assays, at least three independent experiments were performed, each with three 
technical replicates. The statistical analysis was performed using the software SigmaPlot 
version 11. All analyses of variance were performed with Two-way ANOVA, followed by 
Holm-Sidak test to evaluate differences between groups and the control exposure. The 
differences were considered statistically significant when p <0.05. All data are expressed 
as mean ± standard deviation (SD). For qPCR analysis, two independent experiments were 
performed with four technical replicates per independent experiment. Cycle threshold (Ct) 
and average PCR efficiency were estimated from the raw fluorescence data, using the 
program Real-Time PCR miner (Zhao and Fernald, 2005). These parameters were used to 
calculate relative gene expression according to the Pfaffl method (Pfaffl, 2001), using 
GAPDH as a reference gene for data normalization. Data are expressed as mean relative 
gene expression ± standard error of the mean (SEM). 
 
 
Results  
1. Viability analyses  
              1.1. Sulforaphane effects in MG-63 cells proliferation and culture confluence 
Control MG-63 cells presented typical proliferation and fibroblastic morphology under the 
growth conditions tested, with total confluence being achieved after approximately 3 days 
(Figure 9). Cells treated with SFN showed morphological changes such as cell enlargement 
and loss of adherence, which were more pronounced with increasing SFN concentrations. 
Cell confluence decreased with increasing SFN concentrations, compared to control for 
both exposure times (24 h and 48 h).  
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Figure 9: Effect of different concentration and time exposure to SFN on cell viability and morphology in 
MG-63 cells by inverted microscopy (x100).  
 
 
1.2. Viability assay 
The trypan blue assay was used to asses if SFN could affect cell viability of MG-63 cell 
line. SFN induced a dose-dependent inhibition of cell viability of MG-63 cell line at both 
times (Figure 10). For 10 and 20µM SFN concentrations, cell viability was significantly 
decreased for the 48h exposure period, compared to the control. Moreover, for these 
concentrations there was significant decrease in cell viability from 24 to 48h. 
 
 
Figure 10: Cell viability by trypan blue assay at 24 and 48 h. Data expressed as percentage viable cells. 
Values from 4 independent experiments. * indicates significant differences between treatments and control 
and different letters (a and b) show significant differences for different times (p<0.05).  
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2.  Enzyme assays  
2.1. Superoxide dismutase activity  
A trend for a decrease of SOD activity with increasing SFN concentrations for both times 
of exposure was found.  At 24 h those differences were only significant for the highest 
SFN concentration tested (20 µM). However, at 48 h of exposure this effect was already 
significantly at 10 µM SFN. Data also show that for 10 and 20 µM SFN, SOD activity 
decreased significantly between the 24 and 48 h exposure times (Figure 11). 
 
 
Figure 11: SOD specific activity. Values from 6 independent experiments ± SD. * indicates significant 
differences between treatments and control and different letters (a and b) show significant differences for 
different times (p<0.05). 
 
2.2. Glutathione peroxidase activity 
GPx activity decreased with increasing SFN concentrations (Figure 12). For the control, 
GPx activity increased significantly from 24 h to 48 h. However, with increasing SFN 
concentrations, GPx activity did not increase between 24 h and 48 h exposure. Compared 
to the control, GPx activity was significantly reduced for 10 and 20 µM SFN for both 
exposure times. Moreover, for the longer exposure period (48 h), exposure to 5µM SFN 
also resulted in a significant decrease in GPx activity.  
0
20
40
60
80
100
120
140
0 5 10 20
S
O
D
 a
ct
iv
it
y
 (
U
/m
g
 p
ro
te
in
 
SFN concentration (µM) 
24h
48h
* * 
* 
a 
a 
a a a 
b a 
b 
37 
 
 
Figure 12: GPx specific activity. Values from 3 independent experiments ± SD. * indicates significant 
differences between treatments and control and different letters (a and b) show significant differences for 
different times (p<0.05). 
 
2.3. Glutathione Reductase activity 
GR activity decreased significantly after 48 h for 10 and 20 µM SFN comparatively to the 
control (Figure 13). GR activity was also affected between different exposure times for the 
control and lowest concentration of SFN tested, showing a significant increase from 24 h 
to 48 h of exposure period. Enzyme activity was extremely low for the longest exposure 
period tested of 48 h at the highest SFN concentration (20 µM).  
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Figure 13: GR specific activity. Values from 4 independent experiments ± SD. * indicate significant 
differences between treatments and control and different letters (a and b) show significant differences for 
different times (p<0.05).  
 
2.4. Reduced glutathione (GSH)  
SFN exposure significantly increased total glutathione content for the shortest exposure 
period and lowest concentration tested i.e. 24 h exposure to 5 µM SFN. The general trend 
for GSH levels was an increase after exposure to 5 µM SFN, followed by decreased GSH 
levels at increasing SFN concentrations (Figure 14).  
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Figure 14: Normalized reduced glutathione levels. Values from 4 independent experiments ± SD. * indicates 
significant differences between treatments and control and different letters (a and b) show significant 
differences for different times (p<0.05).   
 
3. Total antioxidant activity (TAA) 
TAA in MG-63 homogenates was significantly decreased for the dose of 20 µM SFN. This 
effect was significant for both exposure periods. The length of exposure time also affected 
TAA, as the longer 48 h period resulted in significantly higher TAA values, relative to 24 h 
(Figure 15). 
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Figure 15: Total Antioxidant activity. Results are expressed as mean ± SD. Values from 3 independent 
experiments. * indicates significant differences between treatments and control and different letters (a and b) 
show significant differences for different times (p <0.05).  
 
4. Lipid peroxidation (TBARS) 
In this assay, a global decrease in TBARS levels was observed with increasing SFN 
concentrations (Figure 16). A significant decrease in TBARS levels was observed after 48 
h exposure to SFN concentrations between 5 and 20 µM. For the 24 h exposure period, 
only the largest SFN concentration tested (20 µM) decreased significantly TBARS levels.  
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Figure 16: Lipid peroxidation. Results are expressed as mean ± SD. Values from 5 independent experiments 
± SD. * indicates significant differences between treatments and control and different letters (a and b) show 
significant differences for different times (p <0.05).  
 
 
4.1. Protein quantification in lipid peroxidation assay  
In this assay, a global decrease in protein levels was observed with increasing SFN 
concentrations (Figure 17). A significant decrease in protein levels was observed after 24 
and 48 h exposure to SFN concentrations of 10 and 20 µM.  The length of exposure time 
also affected protein levels, as the longer 48 h period resulted in significantly higher 
protein values, relative to 24 h.  
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Figure 17: Protein values used in lipid peroxidation assays. Results are expressed as mean ± SD. Values from 
5 independent experiments ± SD. * indicates significant differences between treatments and control and 
different letters (a and b) show significant differences for different times (p <0.05).  
 
5.  Enzyme gene expression  
Gene expression analysis of enzymes known to be involved in oxidative stress response 
was performed for control condition and for cells exposed to 10 µM SFN for 48 h. The 
experimental condition was chosen based on the significant effects produced on cell 
viability and enzyme activities for SOD, GPx and GR. For a 2-fold cutoff of expression, 
SOD1 gene, encoding Cu-Zn SOD, was overexpressed in SFN-exposed cells relative to 
control, whereas GPX and GSTM4 encoding GPx and Glutathione-S-Transferase isoform 
M4 were underexpressed. GSR gene, enconding GR, and GSTM1 gene, encoding 
Glutathione-S-Transferase isoform M1 showed expression levels similar to the control, for 
a 1.5-fold cutoff (Figure 18).    
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Figure 18: Relative expression (normalized ratios), SFN exposure (10µM) versus control. Gene expression 
related with the enzymes that interferes with oxidative stress for 48h. Results are expressed as mean ± SD. 
Method used was the Pfaffl with Ct and average efficiency parameters. Values from 2 independent 
experiments with 4 replicates each.             (reference value) 
  
 
Discussion 
SFN is a plant-derived ITC, which has been shown to display preventive activity against 
different tumor types. The nature and intensity of SFN effects have been described to 
depend on SFN concentration, time of exposure, the cell line, or tissue treated (Fimognari 
et al, 2005; Song et al, 2009). Various ITCs including SFN prevent oxidative damage in 
the cell, and Hu et al (2007) proposed that this preventive action can be achieved by 
nuclear factor E2-related factor 2 (Nrf2)-mediated induction of phase II detoxification 
enzymes. However, other studies reported that this preventive effect may be dose 
dependent and that SFN may have negative effects, mostly at high doses (e.g. Zanichelli et 
al, 2012). Also the influence of SFN on the major antioxidant enzymes (besides Phase II) 
in tumor cells (CAT, SOD, GPX, GR) remain unclear, and this clarification in 
osteosarcoma was the main aim of this work. 
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Therefore the present study was undertaken to investigate putative chemotherapeutic 
effects of SFN on MG-63 osteosarcoma cell line in vitro. For this, MG-63 cells were 
exposed to SFN concentrations previously described as physiologically attainable in the 
human plasma, e.g. up to 10 µM SFN (Gasper et al, 2005), and also to the higher dose of 
20 µM SFN for 24 and 48h. 
Data of cell viability showed that SFN exposure caused cell death in a concentration and 
time dependent manner, so a decrease in cell viability and proliferation occurred, as 
expected. These gradual concentration and time dependent effects quantitatively supported 
the visual analyses in which cultures with SFN showed a decrease in confluence and a 
general increase in the percentage of cells detached from the plate. One of the first lines of 
antioxidant defenses are the enzymatic antioxidant defenses. Small disturbances in this 
system can immediately lead to oxidative stress resulting in various damages to cells 
(Peixoto et al, 2004; Ascenso et al, 2011). The mechanisms by which SFN disrupts 
oxidative defenses are not fully understood yet. As stated above for other tissues, SFN may 
interfere with the Nrf2-mediated induction of phase II detoxification enzymes. According 
to few studies, disturbed redox equilibrium leads to modulation of redox sensitive 
transcription factors such as Nrf2, AP-1 and NF-kB that transduce alterations in the 
cellular redox status. Such alterations in cellular redox status can result in gene expression 
responses. Nrf2 binds to antioxidative response elements (AREs) and induces transcription 
of phase II detoxification and antioxidative enzymes. These enzymes improve cell defense 
against oxidative damage and promote the removal of carcinogens (Zhang et al, 2006; Hu 
et al, 2007; Juge et al, 2007).  
The gene expression of the transcription factor Nrf2, was shown to be up-regulated in 
osteoblasts under exposed to oxidative conditions (Arai et al 2007), but it remains unclear 
if and how other signaling pathways may also be involved in these cells (e.g. Xu et al 
2010). These cells are prone to redox signaling, so being particularly sensitive to 
alterations on oxidative state (Almeida M, 2011; Zhou H et al, 2011). Moreover, the action 
of SFN on osteoblasts oxidative stress regulation remains unknown. 
As reported above, cellular antioxidant defenses include the SOD, GPx, CAT and GR 
enzymes that act sequentially to scavenge free radicals (Betteridge, 2000). In our 
experiment, SOD activity showed a decrease with increasing SFN concentrations for both 
times of exposure. This decrease in SOD activity is probably due to a perturbation of 
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cellular redox balance, caused by the excess ROS that can overwhelm the capacity of the 
antioxidant system. Oxidative stress is a condition of imbalance between ROS formation 
and cellular antioxidant capacity due to enhanced ROS generation and/or dysfunction of 
the antioxidant system (Jung and Kwak, 2010).  Data also show that for 10 and 20 µM 
SFN, SOD activity is significantly decreased between the 24 and 48 h exposure times, once 
again demonstrating the time effect in treated cells. 
Activities of the antioxidant enzymes in mouse liver and different brain regions were 
studied in order to demonstrate that different tissues may also express different enzyme 
activities, which may result in different reaction to oxidative stress (Yang et al, 2006). An 
example is the GR activity that was consistently reported as inhibited by SFN in diverse 
types of cell lines, such as Hepa1c1c7, HepG2, MCF7, MDA-MB-231, LNCaP, and HT-29 
cells, while in other cell lines, such as HeLa cells, GR is induced by SFN (Jiang et al, 
2003). In this work, the GR and GPx activities suffered a significant decrease after the 48 h 
of exposure to 10 and 20 µM SFN, comparatively to the control, and an increase for the 
control and lowest concentration of SFN tested, for both periods. GR enzyme activity was 
extremely low for the longest exposure period tested of 48 h at the highest SFN 
concentration (20 µM). These results occur probably because of GSH depletion caused by 
SFN (data shown in this work), since both enzymes interfere with glutathione cycle. GR 
recycles glutathione disulfide (GSSG) and keeps it in the functional status (form sulfhydryl 
GSH) and GPx uses hydrogen peroxide and reduced glutathione (GSH) generating H2O 
and oxidized glutathione (GSSG) (Saydam et al, 1997; Peskin and Winterbourn, 2000; Hu 
et al, 2007; Kim et al, 2010). GPx uses the reductive power of reduced glutathione (GSH), 
so it is linked to the GSH/GSSG cellular content. So, depending (possibly) on the GSH 
content, alterations in GPx and GR activity suffer also changes, as observed in this work.  
GSH is a low molecular thiol that besides being a GPx substrate, also may act, alone, as an 
antioxidant agent. It is reported that GSH is responsible for almost 80% of total radical 
scavenging in cell (Singhal et al, 1987).  
Studies demonstrating the SFN preventive potential show that it can alleviate cells from 
chemically-induced oxidative stress (Song et al, 2009; Gan et al, 2010), despite the fact 
that over time and at high concentrations, SFN may react with and deplete the intracellular 
GSH pool. SFN conjugates with GSH in rats and humans (Zhang, 2002). Therefore, the 
conjugating potential of SFN with GSH in cells appears to be critically important for the 
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induction of phase 2 enzymes (Kim et al, 2003). In this thesis, higher concentration of SFN 
lead to a decrease of GSH levels, which explains the decrease in GR and GPx activities. 
These effects cause an increase in cellular ROS levels (data not show). The increase in 
ROS also corroborates the results obtained in this thesis, namely antioxidant defenses 
decrease, increase of ROS levels leading to oxidative stress.    
Gene expression analysis of enzymes known to be involved in oxidative stress response 
was performed for control condition and for cells exposed to 10 µM SFN. This 
concentration was chosen based on the absence of significant differences between control 
and 5µM and the extensive cell damage found in 20µM SFN exposed samples. The time 
used for analysis was 48h, since this was the exposure time which showed significant 
effects on cell viability and enzyme activities for SOD, GPx and GR.  
The results mentioned before are in agreement with the results obtained for gene 
expression, where a decrease in gene expression is observed for GPx and GR. Contrarily to 
the most of genes analyzed in our work which were either underexpressed (GPx, GSTM4) 
or unchanged in expression (GSR, GSTM1) for a 1.5-fold cutoff, the SOD genes were 
overexpressed in SFN-exposed cells relative to control, contrarily to SOD activity data 
(decrease activity). SFN may decrease SOD activity at a post-transcriptional level. 
Alternatively, SOD gene expression might change throughout time. So, it is necessary to 
perform a blotting (protein analysis) to understand the SFN action. In general, our data 
show that SFN has different effects on the transcription of the studied enzymes: it 
stimulates the transcription of SOD, while represses the transcription of GPx and of 
GSTM4). 
It is also possible to explain the small increase of GSH since for 10µM of SFN at 48h, a 
slight decrease was observed in GSTM4 expression. SFN has the capacity to induce the 
expression of phase II enzymes that may lack the ARE element, such as the different GST 
variants, so if the GSTs catalyze the conjugation of GSH to a wide variety of endogenous 
and exogenous electrophilic compounds, it is possible understand the connection of these 
two molecules (Kim et al, 2003; Townsend et al, 2003). It is feasible to assume that if less 
GST is produced, free unconjugated GSH levels remain high, leading to an increase in GPx 
and GR activities for low concentrations at 48h. So, it is possible that SFN at low 
concentrations leads to an increase in GSH levels. Several studies demonstrate that ITCs, 
such as SFN may be considered hormetic molecules, which means that these compounds 
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are able to induce biologically opposite effects at different doses; usually, there is a 
stimulatory or beneficial effect at low doses and an inhibitory or toxic effect at high doses 
(Zanichelli et al, 2012). Toxic effects of ITCs may be associated with their pro-oxidant 
activities. High concentrations of ITCs rapidly accumulate into cells and can react and 
inactivate –SH groups, as the case of glutathione, which is a potent reactive oxygen 
scavenger (Zanichelli et al, 2012). Low doses of these compounds have a beneficial effect, 
leading to an increase of GSH levels (Singhal et al, 1987). 
In order to understand the antioxidant process, it is also necessary to analyze catalase. 
Relatively to this enzyme, the preliminary results indicate that both CAT activity and 
expression levels decrease upon exposure to SFN (unpublished data). However, more 
studies are necessary to confirm these preliminary results.   
 
A large number of antioxidants (macro and micro molecules, and enzymes) exist in living 
organisms, which represent the total antioxidant activity of the system, playing an essential 
role in preventing oxidative stress. For that reason, quantitative measurement of the total 
antioxidant capacity may provide important biological information (Ronald et al, 1999). 
SFN plays signiﬁcant roles in the prevention of cancer development because this 
compound acts indirectly by several independent mechanisms, in order to increase the 
antioxidant capacity of animal cells and their abilities to handle oxidative stress (Priya et 
al, 2011). In this study an increase was observed in TAA with time for low concentrations, 
probably due to the induction of some enzymes such as GR and GPx. TAA in MG-63 was 
significantly decreased for the 20 µM SFN exposure, an effect most significant for the 24 h 
exposure period. The length of exposure also affected TAA, as the longer 48 h period 
resulted in significantly higher TAA values, than those obtained for 24 h. Nevertheless, as 
SFN concentration increased the TAA decreased, and this is consistent with the results 
obtained, i.e. inhibition of the antioxidant enzymes. Importantly, the cellular TAA 
decreases only for the higher and most cytotoxic SFN concentration tested (20 µM), which 
suggests that SFN triggers an antioxidant defense (e.g. by modulating Phase II enzymes) as 
reported for other tumor cells (Bonnesen et al, 2001). 
Lipid peroxidation occurs when ROS are generated close to, or within membranes and 
attack the fatty acid side chains of membrane phospholipids (Farias et al, 2011). Our 
results showed a global decrease in TBARS levels with increasing SFN concentration. A 
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significant decrease in TBARS levels was observed after 48 h exposure to SFN 
concentrations between 5 and 20 µM.  For the 24 h exposure period, only the largest SFN 
concentration tested (20 µM) was associated with significantly decreased TBARS levels.  
The results obtained in this assay showing TBARS decrease did not match the other data 
obtained in this work, e.g. antioxidant enzymes decrease. Since TBARS absolute levels 
were normalized to total protein amount, the variation in TBARS levels cannot be 
explained by changes in protein content. More studies in this field are needed, e.g. other 
lipid peroxidation assays or studies on gene expression of related genes in order to confirm 
these results or to understand if there is protection of membrane lipids. Finaly it should not 
be excluded the hypothesis of a putative interference of the SFN per se on the TBARS 
method, so hampering the use of this method.   
 
Overall, these data show that SFN affects antioxidant enzymes (at transcriptional or pos 
transcriptional levels). Data also show that this regulation is a concerted one of GR, GPx, 
GST, glutathione and other redox components, which define the complexity of the redox 
regulation used in cell defenses against oxidative and electrophilic species. This protective 
regulation is likely to be more susceptible to oxidative stress and disturbed redox balance 
in malignant cells, and this susceptibility in malignant cells probably contributes to the 
cytotoxic effects of chemopreventive compounds against tumor cells. 
  
Conclusions and Future Perspectives 
In conclusion, these results suggest that SFN can induce physiological alterations on MG-
63 cell line by the disruption of cellular redox state. In particular SFN leads to a decrease 
on SOD, GR, GPx and possibly CAT activity as well. In high concentrations (higher than 
10 µM) SFN causes the depletion of antioxidative defenses, namely, SOD, GR, GPx, and 
GSH content, leadings to oxidative stress inducing damages in the cells leading to cell 
death (figure 19). 
More studies are necessary to support other markers/pathways of the oxidative stress: e.g. 
meanwhile found CAT activity/expression (data not shown). Also the effects of SFN on 
mitochondrial parameters related to ROS formation (and eventually with the apoptosis) 
may provide further evidence to the mechanisms of SFN targeting the tumor/osteosarcoma 
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cells, and therefore induce oxidative stress on it. So, this may provide a complementary 
mechanism/pathway of studying SFN as chemotherapeutic drug for this tumor.  
Below we propose the current model of action of the SFN on osteosarcoma, based on the 
data obtained in vitro with MG-63 cells. 
 
 
Figure 19: Proposed model of the SFN effects on antioxidant defenses of osteosarcoma cells. This model is 
based on the data of this work, and on other literature – in blue (e.g. Costa et al, 2012; Pinto, 2011).  
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